Jason P Trama1, Martin E Adelson, Eli Mordechai. 1. Molecular and Cellular Biology Division, Medical Diagnostic Laboratories LLC, 2439 Kuser Road, Hamilton, NJ 08690, United States. jtrama@mdlab.com
Abstract
BACKGROUND: Laboratory diagnosis of molluscum contagiosum virus (MCV) is important as lesions can be confused with those caused by Cryptococcus neoformans, herpes simplex virus, human papillomavirus, and varicella-zoster virus. OBJECTIVES: To develop a rapid method for identifying patients infected with MCV via swab sampling. STUDY DESIGN: Two dual-labeled probe real-time PCR assays, one homologous to the p43K gene and one to the MC080R gene, were designed. The p43K PCR was designed to be used in conjunction with Pyrosequencing for confirmation of PCR products and discrimination between MCV1 and MCV2. RESULTS: Both PCR assays were optimized with respect to reaction components, thermocycling parameters, and primer and probe concentrations. The specificities of both PCR assays were confirmed by non-amplification of 38 known human pathogens. Sensitivity assays demonstrated detection of as few as 10 copies per reaction. Testing 703 swabs, concordance between the two real-time PCR assays was 99.9%. Under the developed conditions, Pyrosequencing of the p43K PCR product was capable of providing enough nucleotide sequence to definitively differentiate MCV1 and MCV2. CONCLUSIONS: These real-time PCR assays can be used for the rapid, sensitive, and specific detection of MCV and, when combined with Pyrosequencing, can further discriminate between MCV1 and MCV2.
BACKGROUND: Laboratory diagnosis of molluscum contagiosum virus (MCV) is important as lesions can be confused with those caused by Cryptococcus neoformans, herpes simplex virus, human papillomavirus, and varicella-zoster virus. OBJECTIVES: To develop a rapid method for identifying patients infected with MCV via swab sampling. STUDY DESIGN: Two dual-labeled probe real-time PCR assays, one homologous to the p43K gene and one to the MC080R gene, were designed. The p43K PCR was designed to be used in conjunction with Pyrosequencing for confirmation of PCR products and discrimination between MCV1 and MCV2. RESULTS: Both PCR assays were optimized with respect to reaction components, thermocycling parameters, and primer and probe concentrations. The specificities of both PCR assays were confirmed by non-amplification of 38 known human pathogens. Sensitivity assays demonstrated detection of as few as 10 copies per reaction. Testing 703 swabs, concordance between the two real-time PCR assays was 99.9%. Under the developed conditions, Pyrosequencing of the p43K PCR product was capable of providing enough nucleotide sequence to definitively differentiate MCV1 and MCV2. CONCLUSIONS: These real-time PCR assays can be used for the rapid, sensitive, and specific detection of MCV and, when combined with Pyrosequencing, can further discriminate between MCV1 and MCV2.
Authors: Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König Journal: Transfus Med Hemother Date: 2010-11-17 Impact factor: 3.747
Authors: Jeffrey I Cohen; Wilmer Davila; Mir A Ali; Siu-Ping Turk; Edward W Cowen; Alexandra F Freeman; Kening Wang Journal: J Infect Dis Date: 2012-01-19 Impact factor: 5.226
Authors: Ariana Harari; Charles E Wood; Koenraad Van Doorslaer; Zigui Chen; Marie Claire Domaingue; David Elmore; Patricia Koenig; Janice D Wagner; Ryan N Jennings; Robert D Burk Journal: Toxicol Pathol Date: 2012-12-21 Impact factor: 1.902
Authors: Katarina Trčko; Lea Hošnjak; Blanka Kušar; Tomaž Mark Zorec; Boštjan J Kocjan; Miljenko Križmarić; Katja Seme; Jovan Miljković; Boštjan Luzar; Mario Poljak Journal: Open Forum Infect Dis Date: 2018-11-12 Impact factor: 3.835
Authors: Tomaž M Zorec; Denis Kutnjak; Lea Hošnjak; Blanka Kušar; Katarina Trčko; Boštjan J Kocjan; Yu Li; Miljenko Križmarić; Jovan Miljković; Maja Ravnikar; Mario Poljak Journal: Viruses Date: 2018-10-26 Impact factor: 5.048